Synovial butorphanol concentrations and mechanical nociceptive thresholds after intravenous regional limb perfusion in standing sedated horses.
Authors: Crabtree Naomi E, Mochal-King Cathleen A, Sloan Pearce B, Eddy Alison L, Wills Robert W, Meredith Ashley N, Fontenot Robin L
Journal: Veterinary surgery : VS
Summary
# Synovial Butorphanol After Intravenous Regional Limb Perfusion in Horses Intravenous regional limb perfusion (IVRLP) offers an attractive route for delivering analgesics directly to affected joints whilst minimising systemic exposure, but optimal dosing strategies remain unclear. Researchers administered 10 mg butorphanol via cephalic IVRLP to six standing sedated horses using a tourniquet, then tracked drug concentrations in radiocarpal synovial fluid and serum alongside mechanical nociceptive thresholds (MNT) over six hours. Peak synovial concentrations of 9.47 ng/mL appeared within 30 minutes and remained detectable above baseline for four hours, whilst serum levels peaked at 3.89 ng/mL but cleared within two hours—suggesting the tourniquet effectively contained the drug locally. Surprisingly, mechanical nociceptive testing revealed only a marginal increase in pain threshold one hour post-perfusion in treated horses compared to controls, raising questions about whether 10 mg achieves sufficient synovial concentrations for meaningful analgesia despite adequate drug delivery. Whilst IVRLP proved well tolerated as a delivery method, these results suggest current dosing protocols may be subtherapeutic for joint analgesia; practitioners considering this technique should recognise that measurable drug presence does not guarantee clinical pain relief, and further research into dose escalation or alternative agents is warranted before incorporating IVRLP butorphanol into routine lameness management protocols.
Read the full abstract on PubMed
Practical Takeaways
- •IVRLP is a feasible technique for delivering butorphanol to synovial structures, with local concentrations maintained for 4 hours—potentially useful for managing joint pain in lame horses
- •Current 10 mg butorphanol dose via IVRLP achieved measurable but suboptimal analgesic effects; higher doses or alternative delivery protocols may be needed for clinical analgesia
- •This technique offers an alternative to intra-articular injection for horses where direct joint access is challenging or undesirable, though efficacy requires further refinement
Key Findings
- •Butorphanol reached peak synovial fluid concentrations of 9.47 ng/mL within 30 minutes of intravenous regional limb perfusion (IVRLP)
- •Detectable butorphanol levels persisted in synovial fluid for 4 hours post-IVRLP, significantly longer than serum levels (2 hours)
- •Only statistically significant mechanical nociceptive threshold difference occurred at 1 hour post-IVRLP, where control horses had higher thresholds than treated horses
- •IVRLP with butorphanol was well tolerated in all horses with successful synovial delivery in 5 of 6 animals